Fair Prices, Consumer Education, Industry Accountability
  • Home
  • About Us
    • About PAL
    • Staff
    • PAL Coalition
    • Lawyers
    • Funders
    • Leadership Circle
    • Directing cy pres awards to PAL and Community Catalyst
    • Internship Opportunities
  • Lawsuits & Settlements
    • Current Lawsuits
    • Past Lawsuits
    • Settlements
    • Suggest a New Case
    • FAQ
    • Amicus Briefs
    • Cy Pres
  • Press
    • Press Releases
    • Press Coverage
    • Media Inquiries
  • Learn More
    • Copay coupons
    • Generic Drugs
    • Pay-for-Delay Settlements
    • Direct-to-Consumer-Advertising (DTCA)
    • Prescription Access and Quality (Community Catalyst)
    • Drug Pricing
    • Pharmacy Benefit Managers
  • Publications
    • Newsletters
    • Articles
    • Amicus Briefs
    • Testimony & Comments
    • Brochure (.pdf)
  • Coalition
    • Current Members
    • How to Join
  • Donate
  • Contact Us
  • Blog
    • PAL Blog
    • Health Policy Hub
    • Postscript
Lawsuits & Settlements
  • Current Lawsuits
  • Past Lawsuits
  • Settlements
  • Suggest a New Case
  • FAQ
  • Amicus Briefs
  • Cy Pres
Get updates on drug lawsuits, settlements and PAL news
Are You Fed Up with High Drug Prices? Get Involved. Tell Us Your Story.

Past Lawsuits

  • Adalat
  • Augmentin
  • Average Wholesale Price
  • Bextra
  • BuSpar
  • Celebrex
  • Cipro
  • Claritin
  • Estratest
  • First Databank McKesson Medispan
  • Imodium
  • K-Dur
  • Ketek
  • Lipitor
  • Lupron
  • Neurontin - Antitrust Case (Suppression of Generic Versions)
  • Norvir
  • OxyContin
  • Pharmacy Benefit Managers
  • Protonix
  • Relafen
  • Remicade
  • Serostim
  • Tamoxifen
  • Wellbutrin
  • Vioxx
  • Vytorin-Zetia

A Community Catalyst Initiative

Copyright © 2010 Prescription Access Litigation, a project of Community Catalyst, Inc.
All Rights Reserved. Contact Us | Privacy Policy | Legal Disclaimer
Site by: Trilogy

Your Interest Area:

Check/Uncheck All Select all in category 

Children's Health

Chronically Ill and Dually Eligible Populations

Consumer Engagement & Organizing

Cost & Quality

Coverage for the Uninsured

Free Care & Community Benefits

Health Care Equity

Integrated Care Systems

Medicaid

Medical Debt

Medicare

National Health Reform

Nonprofit to For-profit Conversion

Oral Health

Prescription Drug Issues

Prescription Drugs (legal action)

State Health Reform

  

Thank you for your subscription.

If you are not automatically returned to the website momentarily, please click the Refresh button on your browser toolbar.